Cannlabs Financial Statements From 2010 to 2024

CANL Stock  USD 0.0001  0.00  0.00%   
Cannlabs financial statements provide useful quarterly and yearly information to potential Cannlabs investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cannlabs financial statements helps investors assess Cannlabs' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cannlabs' valuation are summarized below:
Cannlabs does not presently have any fundamental signals for analysis.
Check Cannlabs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cannlabs' main balance sheet or income statement drivers, such as , as well as many indicators such as . Cannlabs financial statements analysis is a perfect complement when working with Cannlabs Valuation or Volatility modules.
  
This module can also supplement various Cannlabs Technical models . Check out the analysis of Cannlabs Correlation against competitors.

Cannlabs Company Current Valuation Analysis

Cannlabs' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Cannlabs Current Valuation

    
  14.91 M  
Most of Cannlabs' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannlabs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Cannlabs has a Current Valuation of 14.91 M. This is 99.9% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.91% higher than that of the company.

Cannlabs Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cannlabs's current stock value. Our valuation model uses many indicators to compare Cannlabs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cannlabs competition to find correlations between indicators driving Cannlabs's intrinsic value. More Info.
Cannlabs is number one stock in return on asset category among its peers. It also is number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cannlabs' earnings, one of the primary drivers of an investment's value.

About Cannlabs Financial Statements

Cannlabs investors utilize fundamental indicators, such as revenue or net income, to predict how Cannlabs Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
CannLabs, Inc. provides cannabis testing laboratory services in the United States. The company also offers dataanalytics and consulting, as well as education services. Cannlabs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 37 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Cannlabs Pink Sheet

Cannlabs financial ratios help investors to determine whether Cannlabs Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannlabs with respect to the benefits of owning Cannlabs security.